Structural and Functional Measures of Efficacy in Response to Bevacizumab Monotherapy in Diabetic Macular Oedema: Exploratory Analyses of the BOLT Study (Report 4)-Reference-Cited by-同舟云学术

Structural and Functional Measures of Efficacy in Response to Bevacizumab Monotherapy in Diabetic Macular Oedema: Exploratory Analyses of the BOLT Study (Report 4)

Published:2013-08-27 Issue:8 Volume:8 Page:e72755
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Sivaprasad Sobha,Crosby-Nwaobi Roxanne,Esposti Simona,Peto Tunde,Rajendram Ranjan,Michaelides Michel,Hykin Philip

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference20 articles.

1. Global estimates of visual impairment: 2010;D Pascolini;Br J Ophthalmol,2012

2. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1;Arch Ophthalmol,1985

3. Elman MJ, Aiello LP, Beck RW, Bressler NM, Bressler SB, et al.. (2010) Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 117: 1064–1077 e1035.

4. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema;P Mitchell;Ophthalmology,2011

5. Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study;P Massin;Diabetes Care,2010

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Short-Term Effects of Adding Topical Ketorolac to Intravitreal Bevacizumab in Diabetic Macular Edema: A Crossover Randomized Clinical Trial;Journal of Ophthalmic and Vision Research;2024-03-10

2. Does dexamethasone implant combination with aflibercept monotherapy affect one-year outcomes in treatment-naive diabetic macular edema with inflammatory biomarkers?;International Ophthalmology;2024-02-09

3. Does Dexamethasone implant Combination with Aflibercept monotherapy have an effect on 1-year outcomes in treatment-naive Diabetic Macular Edema with Inflammatory Biomarkers?;2023-10-05

4. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis;Cochrane Database of Systematic Reviews;2023-06-27

5. Ranibizumab versus aflibercept for diabetic macular edema: 18-month results of a comparative, prospective, randomized study and multivariate analysis of visual outcome predictors;Cutaneous and Ocular Toxicology;2020-08-09